SCL Science Inc (246960) Fair Value & Analysis
Healthcare · KR · Market cap 14.8B KRW
Fair value as of: Jul 7, 2026
From 1 valuation models · updated today
Fair value updated Jul 7, 2026 — revised from 12,955 KRW to 1,929 KRW (−85.1%) since Jun 24, 2026. Share price −9.3% over the past month.
Price vs Fair Value (12 months)
12‑month range 1,552 KRW – 4,040 KRW · fair‑value band 1,439 KRW – 2,879 KRW · the 1,699 KRW price screens below the 1,929 KRW fair value. As of Jul 7, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
SCL Science Inc (246960) currently trades at 1,699 KRW, while our model-based Fair Value estimate is 1,929 KRW — implying the stock looks roughly 13.5% undervalued today. We read business quality at 24/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, SCL Science Inc generated revenue of 27.4B KRW at a net margin of -11.6%. Revenue grew 237.9% year over year. It earns a return on equity of -13.3%. Net debt stands at 18.3B KRW. Fundamentals as of Jul 7, 2026
Our scenario range runs from 1,439 KRW (bear case) to 2,879 KRW (bull case); at 1,699 KRW, the current price sits within that range. The share trades about 67% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -28% fair-value upside — at 14%, 246960 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 7, 2026. TTM = trailing twelve months.
About the company
SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasis and sealing products; STOP, a non-bleeding intravascular injection; Film that prevents leakage at intestinal and vascular anastomosis sites; InnoLOCK and InTro vascular interventional procedure items; and operates bio-logistics business. The company also engages in conducting clinical trial analysis services related to new drug development, in vitro diagnostic medical device performance evaluation, transportation of pharmaceuticals and clinical trial samples, etc. The company was formerly known as InnoTherapy, Inc. and changed its name to SCL Science Inc. in March 2024. SCL Science Inc. …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
SCL Science Inc reported revenue of 22.0B KRW in FY2025 versus 507M KRW in FY2021, a compound +156.7%/yr. Reported net income was −3.9B KRW in FY2025.
Is 246960 fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABTT34 | R$39.41 | R$30.42 | -23% |
| Stryker Corporation S1YK34 | R$79.21 | R$43.74 | -45% |
| Medtronic plc MDTC34 | R$210.63 | R$24.08 | -89% |
| Boston Scientific Corporation B1SX34 | R$229.30 | R$43.33 | -81% |
| Edwards Lifesciences Corporation EW | $87.45 | $41.02 | -53% |
| Siemens Healthineers AG SEMHF | $40.29 | $47.96 | +19% |
| GE HealthCare Technologies Inc GEHC | $61.99 | $48.34 | -22% |
| DexCom, Inc DXCM | $74.77 | $53.93 | -28% |
| Koninklijke Philips N.V 1PHIA | €24.31 | €9.97 | -59% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥143.50 | ¥111.50 | -22% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is SCL Science Inc (246960) undervalued?
What is the fair value of 246960?
What is the quality score of 246960?
What is the revenue of SCL Science Inc (246960)?
What is the net profit margin of 246960?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.